Liver Transplantation as Treatment for Budd–Chiari Syndrome: Case Report

Authors

DOI:

https://doi.org/10.22516/25007440.1299

Keywords:

Polycythemia vera, Budd-Chiari syndrome, liver transplantation, acute myeloid leukemia secondary to myelodysplastic syndrome

Abstract

Background: Polycythemia vera is a myeloproliferative neoplasm that leads to hyperviscosity, blood stasis, and a high risk of thrombotic complications. When these events affect the hepatic veins, they give rise to Budd–Chiari syndrome, characterized by elevated portal capillary hydrostatic pressure, predisposing patients to ascites, variceal bleeding, and hepatic dysfunction. Liver transplantation is considered in two principal clinical scenarios: fulminant hepatic failure and progressive cirrhosis, particularly when TIPS is not feasible.

Case summary: We report the case of a 40-year-old woman with polycythemia vera and Budd–Chiari syndrome who, despite successful recanalization of the hepatic veins through anticoagulation, experienced clinical deterioration with progressive portal hypertension and refractory ascites. Her severity score and clinical decline (Rotterdam index 2.7 = class III, poor 3-month prognosis) supported the decision to proceed with a deceased-donor liver transplant, which was successfully performed. Sequential use of antiplatelet therapy, hydroxyurea, and anticoagulation prevented thrombotic complications without inducing bleeding. Outpatient follow-up showed no clinical signs of portal hypertension, including ascites or variceal bleeding.

Conclusion: Budd–Chiari syndrome secondary to myeloproliferative disorders is uncommon, and its management must be individualized according to disease stage, comorbidities, and institutional expertise to achieve optimal patient outcomes.

Downloads

Download data is not yet available.

Author Biographies

Alvaro Montenegro, Clínica Imbanaco

Specialist in Emergency Medicine; Specialist in Critical Care Medicine and Intensive Care; Specialist in Epidemiology. Clínica Imbanaco. Cali, Colombia.

Hernan Florez, Pontificia Universidad Javeriana

Emergency Medicine Resident, Pontificia Universidad Javeriana (PUJ) Cali. Clínica Imbanaco. Cali, Colombia.

Diego Mauricio Gomez, Clinica Imbanaco

Gastroenterology and Hepatology, Liver Transplant Group. Clínica Imbanaco. Cali, Colombia.

Juan Manuel Rico, Clinica Imbanaco

Hepatobiliary and Transplant Surgeon. Clínica Imbanaco. Cali, Colombia.

Michael Zapata, Clinica Imbanaco

General Surgeon. Clínica Imbanaco. Cali, Colombia

Jhonatan Urrego, Clinica Imbanaco

Specialist in Intensive Care. Adult Intensivist at Clínica Imbanaco. Cali, Colombia.

Luis Alfonso Bustamante Cristancho, Clinica Imbanaco

Emergency Physician, Intensivist, Radiologist. ICU Coordinator, Imbanaco. Clínica Imbanaco. Cali, Colombia.

References

Iurlo A, Cattaneo D, Bucelli C, Baldini L. New perspectives on polycythemia vera: From diagnosis to therapy. Int J Mol Sci. 2020;21(16):1-16. https://doi.org/10.3390/ijms21165805

Tefferi A, Rumi E, Finazzi G, Gisslinger H, Vannucchi AM, Rodeghiero F, et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study. Leukemia. 2013;27(9):1874-81. https://doi.org/10.1038/leu.2013.163

Correa-Gaviria S, Ramírez AC, Espinoza-Herrera YP, Restrepo-Gutiérrez JC. A Review of Budd Chiari Syndrome. Rev Colomb Gastroenterol. 2016;31(3):242-52.

Min AD, Atillasoy EO, Schwartz ME, Thiim M, Miller CM, Bodenheimer HC Jr, et al. Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg. 1997;3(4):423-9. https://doi.org/10.1002/lt.500030410

Tefferi A. Myeloproliferative neoplasms: A decade of discoveries and treatment advances. Am J Hematol. 2016;91(1):50-8. https://doi.org/10.1002/ajh.24221

Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A. Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia. 2007;21(9):1960-3. https://doi.org/10.1038/sj.leu.2404810

Pedersen MR, Molloy P, Wood D, Seetharam A. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome. Ann Hepatol. 2016;15(1):127-30. https://doi.org/10.5604/16652681.1184288

Aktas H, Ozer A, Yilmaz TU, Keceoglu S, Can MG, Emiroglu R. Liver transplantation for Budd-Chiari syndrome: A challenging but handable procedure. Asian J Surg. 2022;45(7):1396-402. https://doi.org/10.1016/j.asjsur.2021.09.007

Dongelmans E, Erler N, Adam R, Nadalin S, Karam V, Yilmaz S, et al. Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centers. Hepatology. 2024;80(1):136-51. https://doi.org/10.1097/HEP.0000000000000778

Ibach M, Eurich D, Dobrindt E, Lurje G, Schöning W, Öllinger R, et al. Orthotopic liver transplantation for Budd-Chiari syndrome: Observations from a 30-year liver transplant program. Medicina (Kaunas). 2021;57(8):821. https://doi.org/10.3390/medicina57080821

Doğrul AB, Yankol Y, Mecit N, Kanmaz T, Acarlı K, Kalayoğlu M. Orthotopic liver transplant for Budd-Chiari Syndrome: An analysis of 14 cases. Exp Clin Transplant. 2016;14(6):641-5. https://doi.org/10.6002/ect.2015.0026

Alqahtani SA, Schneider C, Sims OT, Gurakar A, Tamim H, Bonder A, et al. Liver Transplantation for Budd-Chiari Syndrome in the MELD Era. Transplant Direct. 2022;8(12):e1407. https://doi.org/10.1097/TXD.0000000000001407

Morales Cruz XP, Rojas Kozhakin DV. Características clínicas, manejo y sobrevida de pacientes con síndrome de Budd-Chiari en un centro de hepatología colombiano. [Tesis de grado]. [consultado el 24 de agosto de 2024]. Repositorio Universidad del Rosario. 2022. https://doi.org/10.48713/10336_38068

Muñoz-Maya O, Vergara-Cadavid JA, Cajiao-Castro L, Santos OM, Marín-Zuluaga JI, Restrepo-Gutiérrez JC. Síndrome de Budd-Chiari: etiología, manejo y resultados en una cohorte de 35 pacientes del Hospital Pablo Tobón Uribe. Rev. colomb. Gastroenterol. 2019;35(3):280-6. https://doi.org/10.22516/25007440.431

Melear JM, Goldstein RM, Levy MF, Molmenti EP, Cooper B, Netto GJ, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation. 2002;74(8):1090-5. https://doi.org/10.1097/00007890-200210270-00006

Pavri TM, Herbst A, Reddy R, Forde KA. Budd-Chiari syndrome: A single-center experience. World J Gastroenterol. 2014;20(43):16236-44. https://doi.org/10.3748/wjg.v20.i43.16236

Figura 1. Angiotomografía de abdomen con adquisición en fase arterial. Obsérvese la vena hepática derecha con amputación del flujo, sugiriendo oclusión de aspecto crónico identificada con flecha amarilla; con flecha verde se observa la vena hepática media con amputación del flujo, sugiriendo oclusión de aspecto crónico; con flecha roja se encuentra la vena cava inferior retrohepática con disminución del calibre, sin trombosis u oclusiones. Imágenes propiedad de los autores.

Published

2025-12-23

How to Cite

Montenegro, A., Florez, H., Gomez, D. M., Rico, J. M., Zapata, M., Urrego, J., & Bustamante Cristancho, L. A. (2025). Liver Transplantation as Treatment for Budd–Chiari Syndrome: Case Report. Revista Colombiana De Gastroenterología, 40(4), 486–491. https://doi.org/10.22516/25007440.1299

Altmetric

Escanea para compartir
QR Code
Crossref Cited-by logo
Article metrics
Abstract views592
Galley views623
PDF Views584
HTML views0
Other views39

Some similar items: